ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) Return on assets
ResMed Inc.'s return on assets over the twelve months to 30 June 2026 was 17.8%. Over the past ten years it has ranged from 9.66% (fiscal 2018) to 18.6% (fiscal 2025); the current reading is higher than 92% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 17.8% | (0.85) |
| FY2025 | 18.6% | 3.63 |
| FY2024 | 15.0% | (0.16) |
| FY2023 | 15.2% | (0.72) |
| FY2022 | 15.9% | 5.68 |
| FY2021 | 10.2% | (4.11) |
| FY2020 | 14.3% | 3.02 |
| FY2019 | 11.3% | 1.62 |
| FY2018 | 9.66% | (0.52) |
| FY2017 | 10.2% | (2.78) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. | 17.8% |
| WST West Pharmaceutical Services, Inc. compare | 14.1% |
| SOLV Solventum Corporation compare | 9.78% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| MDLN Medline Inc. compare | 3.58% |
| ALC Alcon compare | 2.06% |
| BDX Becton, Dickinson and Company compare | 1.78% |
| RGEN Repligen Corporation compare | 1.42% |
| BAX Baxter International Inc. compare | −5.21% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement